The role of metallothioneins (MTs) in cognitive decline associated with intracellular Zn 2+ dysregulation remains unclear. Here, we report that hippocampal MT induction defends cognitive decline, which was induced by amyloid β 1-42 (Aβ 1-42 )-mediated excess Zn 2+ and functional Zn 2+ deficiency. Excess increase in intracellular Zn
Introduction
Zinc is essential for brain functions and most of zinc is tightly bound to metalloproteins, which require it for catalytic activity or structural stability. Zinc is concentrated in presynaptic vesicles of a subclass of glutamatergic neurons, i.e., zincergic neurons, and is released along with synaptic activity [1, 2] . Extracellular Zn 2+ dynamics, which is often linked with Zn 2+ release from zincergic terminals, is critical for not only synaptic plasticity such as longterm potentiation (LTP) but also synaptic dysfunction associated with cognitive decline [3, 4] . Metallothioneins (MTs) are small, cysteine-rich proteins and bind zinc and copper. They function as metal ion regulation and detoxification [5] . MT-I and MT-II are expressed in all tissues, while MT-III and MT-IV are expressed specifically in the brain [6, 7] and stratified squamous epithelia [8] , respectively. MT-III is highly expressed in zincergic neurons and is most abundantly observed in dentate granule cells [9] .
It is well known that the reactivity and dynamic coordination of MTs with Zn 2+ and Cu + are linked with the biological requirements for controlling these cellular metal ions [10] . MTs are unique biological molecules for buffering Zn 2+ as well as zinc transporters, exporters, and importers. Transient increase in intracellular (cytosolic) Zn 2+ concentration functions as intracellular signaling and is involved in LTP, a cellular mechanism of memory [11] . The expression of MTs is involved in modulating and controlling zinc-dependent cellular signaling [12] . However, MT-III-deficient mice exhibit normal spatial learning and memory [13] . MT-I, II-deficient mice exhibit an impaired rate of spatial learning but once learned retain the information as well as the wild-type mice [14] . Therefore, physiological role of MTs in cognitive function remains unclear.
The basal levels of extracellular Zn 2+ are in the range of low nanomolar concentrations (~10 nM) in the hippocampus and probably increased age-dependently [15, 16] . In the dentate gyrus, non-zincergic perforant pathway innervates dentate granule cells. Therefore, it is estimated that extracellular Zn 2+ concentration is not increased at the perforant pathway synapses even after synaptic excitation. Nonetheless, the rapid excess influx of extracellular Zn 2+ into dentate granule cells, which more readily occurs in aged rats after local injection of 100 mM K + into the dentate molecular layer, is a cause of aged-related cognitive decline [17, 18] . Interestingly, extracellular Zn 2+ influx into dentate granule cells is increased by not only glutamatergic synapse excitation with high K + [17] [18] [19] but also amyloid-β (Aβ), a causative candidate for the pathogenesis of Alzheimer's disease (AD) [20] . The formation of Zn-Aβ in the extracellular compartment rapidly increases both intracellular Zn 2+ and Aβ in dentate granule cells of normal young rats, followed by Aβ 1-42 -induced cognitive decline that is due to increase in intracellular Zn 2+ released from Aβ [21] . Aβ 1-42 -induced cognitive decline is rescued in the presence of not only an extracellular Zn 2+ chelator, CaEDTA, but also an intracellular Zn 2+ chelator, ZnAF-2DA [20] . It is possible that the Aβ 1-42 -induced cognitive decline is increased along with normal aging and is a cause of short-term memory loss in the pre-dementia stage of AD. Therefore, defense strategy against the Aβ 1-42 -induced cognitive decline may lead the elderly to preventing and/or delaying AD pathogenesis.
On the basis of the data that in vivo K d value of Zn 2+ to Aβ may be in the range of~3-30 nM [21] , which is higher than that of MTs (~1 pM) [22] , here, we tested the defensive effect of hippocampal MT induction on cognitive decline, which was induced by Aβ 1-42 -mediated excess Zn 2+ and functional Zn 2+ deficiency. Hippocampal MT induction is of benefit to defend Aβ 1-42 -induced cognitive decline of normal rats. The present study also discusses the physiological role of hippocampal MTs on cellular transient changes in Zn 2+ concentration required for cognitive function.
Materials and Methods

Animals and Chemicals
Male Wistar rats (young, < 20 weeks of age; aged, > 60 weeks of age) were purchased from Japan SLC (Hamamatsu, Japan). All the experiments were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of the University of Shizuoka that refer to the American Association for Laboratory Animals Science and the guidelines laid down by the NIH (NIH Guide for the Care and Use of Laboratory Animals) in the USA. The Ethics Committee for Experimental Animals in the University of Shizuoka has approved this work (approval number 136043).
Synthetic human Aβ 1 -4 2 was purchased from ChinaPeptides (Shanghai, China). ZnAF-2DA, a membranepermeable zinc indicator that was kindly supplied from Sekisui Medical Co., Ltd. (Hachimantai, Japan). ZnAF-2DA is taken up into the cells through the cell membrane and is hydrolyzed by esterase in the cytosol to yield ZnAF-2 (K d = 2.7 × 10 −9 M for Zn 2+ ), which cannot permeate the cell membrane [23, 24] . The fluorescence indicators were dissolved in dimethyl sulfoxide (DMSO) and then diluted to artificial cerebrospinal fluid (ACSF) containing 127 mM NaCl, 2.5 mM KCl, 0.9 mM MgSO 4 , 1.2 mM NaH 2 PO 4 , 1.3 mM CaCl 2 , 21 mM NaHCO 3 , and 3.4 mM D-glucose (pH 7.3).
Most elements in vehicle and ACSF used in the present study are at or below detection limits (< 1 ppb = 15 nM): Li, B, Al, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, Se, Rb, Sr, Mo, Ru, and Cd (Agilent 7700 series ICPMS instrument).
In Vivo LTP
Male rats were anesthetized with chloral hydrate (400 mg/kg) and placed in a stereotaxic apparatus. A bipolar stimulating electrode and a monopolar recording electrode made of tungsten wire attached to an injection cannula (internal diameter, 0.15 mm; outer diameter, 0.35 mm) were positioned stereotaxically so as to selectively stimulate the perforant pathway while recording in the dentate gyrus. The electrode stimulating the perforant pathway was positioned 8.0 mm posterior to the bregma, 4.5 mm lateral, and 3.0-3.5 mm inferior to the dura. A recording electrode was implanted ipsilaterally 4.0 mm posterior to the bregma, 2.5 mm lateral, and 3.0-3.5 mm inferior to the dura. Rats were allowed to recover for 1 week in individual home cages. All the stimuli were biphasic square wave pulses (200-μs width), and their intensities were set at the current that evoked 40% of the maximum population spike (PS) amplitude. Test stimuli (0.05 Hz) were delivered at 20-s intervals to monitor PS amplitude, and PS amplitudes were measured for 20-min for the baseline recording in freely moving and unanesthetized rats. One day later, LTP was induced by delivery of high-frequency stimulation (HFS; 10 trains of 20 pulses at 200 Hz separated by 1 s) and under the same condition. PS amplitudes, which were measured for 10 min, were recorded 1 h and immediately (0 h) before HFS stimulation and 1 h after HFS stimulation, averaged, and expressed as percentages of the mean PS amplitude measured during the 20-min baseline period prior to LTP induction, which was expressed as 100%.
In another experiments, LTP recording was performed 1 h after implantation of the electrodes under anesthetized condition (Figs. 4 and 6 ). After stable baseline recording for at least 30 min, LTP was induced by delivery of high-frequency stimulation (HFS; 10 trains of 20 pulses at 200 Hz separated by 1 s) and recorded for 60 min under the same condition. PS amplitudes (test frequency 0.05 Hz) were averaged over 120-s intervals and expressed as percentages of the mean PS amplitude measured during the 10-min baseline period, which was expressed as 100%. PS amplitudes for the last 10 min were also averaged and represented as the magnitude of LTP.
Slice Preparation
Wistar rats were anesthetized with ether and decapitated in accordance with the Japanese Pharmacological Society guide for the care and use of laboratory animals. The brain was quickly removed and immersed in ice-cold choline-ACSF containing 124 mM choline chloride, 2.5 mM KCl, 2.5 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 0.5 mM CaCl 2 , 26 mM NaHCO 3 , and 10 mM glucose (pH 7.3) to suppress excessive neuronal excitation. Coronal brain slices or horizontal hippocampal slices (400 μm) were prepared in ice-cold choline-ACSF using a vibratome ZERO-1 (Dosaka Kyoto, Japan) in an ice-cold choline-ACSF. Slices were then maintained in ACSF at 25°C for at least 30 min. All solutions used in the experiments were continuously bubbled with 95% O 2 and 5% CO 2 .
In Vivo Zn 2+ Imaging
Saline and ZnCl 2 in saline (100 μM) (1 μl) were bilaterally injected via injection cannulas (internal diameter, 0.15 mm; outer diameter, 0.35 mm) as described above. Twenty-three hours later, saline and 25 μM Aβ 1-42 in saline containing 100 μM ZnAF-2DA (2 μl) were injected in the same manner. Five minutes later, the brain slices were prepared, transferred to a chamber filled with ACSF, loaded with 2 μM Calcium Orange AM in ACSF for 30 min to identify hippocampal regions, and then rinsed in ACSF for at least 15 min. The brain slices were transferred to a recording chamber filled with ACSF. The fluorescence of ZnAF-2 (laser, 488 nm; emission, 505-530 nm) and Calcium Orange (laser, 543 nm; emission, above 560 nm) was captured with a confocal laser-scanning microscopic system. Intracellular Zn 2+ levels in the dentate granule cell layer, which were determined with intracellular ZnAF-2, were represented by the ratio to the control without Aβ in saline expressed as 100%.
In Vivo Immunostaining
Male rats were anesthetized with chloral hydrate (400 mg/kg) and placed in a stereotaxic apparatus. The skull was exposed, two burr holes were drilled, and injection cannulae (internal diameter, 0.15 mm; outer diameter, 0.35 mm) were bilaterally inserted into the dentate granule cell layer (4.0 mm posterior to the bregma, 2.3 mm lateral, 2.9 mm inferior to the dura). Thirty minutes later, following recovery from the insertion damage, 
MT Measurement
The hippocampus excised was homogenized by sonication in 4 volume of ice-cold 0.03 M PBS (pH 7.4) and the homogenates (300 μl) were incubated with silver nitrate solution (20 mg/l, 250 μl) and 0.5 M glycine buffer (pH 8.5, 400 μl) for 5 min. Rat hemolyzed erythrocytes (100 μl) were added to the samples, boiled for 2 min to precipitate excess silver, and centrifuged at 4000g for 5 min at 4°C. This process was repeated three times to obtain the supernatant containing only silver bound to MT proteins. The concentration of MT proteins was calculated from silver concentration in the supernatant as determined by inductively coupled plasma atomic emission spectroscopy (ICP-AES).
Object Recognition Memory
The object recognition tests were performed in a separate cohort of animals. Briefly, injection cannulae (internal diameter, 0.15 mm; outer diameter, 0.35 mm) were bilaterally implanted into the dentate granule cell layer of rats as described above. Five days later, saline or dexamethasone in saline (10 mg/kg) was intraperitoneally (i.p.) injected into the rats once a day for 2 days. One hour after the last injection, rats were allowed to explore an open field (70 × 60-cm arena surrounded by 70-cm-high walls, made of a black-colored plastic) for 10 min. Twenty-three hours later, agents in saline (1 μl) were bilaterally injected via injection cannulae into the dentate granule cell layer of unanesthetized rats at the rate of 0.25 μl/min for 4 min. One hour after injection, rats were trained and tested in a novel object recognition task. Training in the object recognition task took place in the same area used for the open-field exploration. Thus, the open-field exploration was used as a context habituation trial for the recognition memory task. The object recognition test requires that the rats recall which of two earthenware objects they had been previously familiarized with. Training was conducted by placing individual rats in the field, in which two identical objects (objects A1 and A2; sake bottle) were positioned in two adjacent corners, 15 cm from the walls. Rats were left to explore the objects for 5 min. Rats were not used for the test when the total of the object exploration time was less than 20 s. In the test given 1 h after training, the rats explored the open field for 3 min in the presence of one familiar (A) and one novel (B; cup) object. All objects were of similar texture, color, and size, but were a distinctive shape (we confirmed that there was no preference for the objects used). All objects were washed with 70% ethanol between trials. The behavior of the rats was recorded with a video camera during the training and the test phases of the experiment, and then, two people independently measured exploratory time and the averaged time was used. Exploration was defined as sniffing or touching the object with the nose and/or forepaws. A recognition index calculated for each rat was expressed by the ratio T B /(T A + T B ) [T A = time spent to explore the familiar object A; T B = time spent to explore the novel object B].
Data Analysis
Student's paired t test was used for comparison of the means of paired data. For multiple comparisons, differences between treatments were assessed by one-way ANOVA followed by post hoc testing using the Tukey's test (the statistical software, GraphPad Prism 5). A value of p < 0.05 was considered significant. Data were expressed as means ± standard error. The results of statistical analysis are described in each figure legend.
Results
MT Induction Rescues Excess Zn
2+ -Induced Attenuation of LTP
In vivo LTP at medial perforant pathway-dentate granule cell synapses underlies the formation and retention of object and space recognition memory [19, 21] . The effect of MT inducers . a Saline and ZnCl 2 in saline (100 μM) (1 μl) were injected into the dentate granule cell layer of freely moving young rats via an injection cannula at the rate of 0.25 μl/min for 4 min. Twenty-three hours later, saline and ZnCl 2 in saline (100 μM) (1 μl) were injected in the same manner as shown by the arrow. One hour later, high-frequency stimulation (HFS) was delivered (left). Saline/saline, n = 17; saline/ZnCl 2 , n = 4; ZnCl 2 /ZnCl 2 , n = 5; ZnCl 2 /saline, n = 4. The magnitude of LTP (middle). . a Saline and ZnCl 2 in saline (100 μM) (1 μl) were injected in the same manner as Fig. 1a . Twenty-three hours later, saline and Aβ in saline (25 μM) (1 μl) were injected as shown by the arrow (left). Saline/saline, n = 17; saline/Aβ, n = 10; ZnCl 2 /Aβ, n = 5; ZnCl 2 / saline, n = 4. The magnitude of LTP (middle). ***p < 0.001 vs. saline, ## p < 0.01 vs. saline/Aβ (Tukey's test). Representative fEPSP recordings at the time − 24 h (black line), − 20 min (gray line), and 50 min (red line) are shown (right). Scale bar, vertical axis (6 mV), cross axis (5 ms). b Saline and CdCl 2 in saline (100 μM) (1 μl) were injected and treated in the same manner as Fig. 2a (left) . ***p < 0.001 vs. saline, # p < 0.05, ## p < 0.01 vs. saline/Aβ (Tukey's test) (middle). c Saline and corticosterone in saline (100 μM) (1 μl) were injected and treated in the same manner as Fig. 2a (left) . ***p < 0.001 vs. saline, # p < 0.05, ## p < 0.01 vs. saline/Aβ (Tukey's test) (middle). d Saline and ZnCl 2 in saline (100 μM) (1 μl) were bilaterally injected via injection cannulas in the same manner as Fig. 1a . Twenty-three hours later, saline and 25 μM Aβ 1-42 in saline containing 100 μM ZnAF-2DA (2 μl) were injected in the same manner. In vivo Zn 2+ imaging ware performed (left). Intracellular Zn 2+ levels in the dentate granule cell layer (GCL) were represented by the ratio to the control without Aβ in saline expressed as 100% (right). Saline/saline, n = 7; saline/Aβ, n = 10; ZnCl 2 /Aβ, n = 11. ***p < 0.001 vs. saline (control), into the same region. When ZnCl 2 or corticosterone was preinjected into the dentate granule cell layer to induce MT-I and MT-2 [7] , ZnCl 2 -induced attenuation of LTP was rescued (Fig. 1a, b) . When Aβ 1-42 was injected into the dentate granule cell layer, intracellular Zn 2+ determined with intracellular ZnAF-2 was markedly increased in the dentate granule cell layer 5 min after Aβ 1-42 injection (Fig. 2d) and was not increased in the CA1 and CA3 (data not shown). LTP was attenuated 1 h after Aβ 1-42 injection, probably due to the rapid increase in intracellular Zn 2+ [20] . Aβ 1-42 -induced attenuation of LTP was rescued by the preinjection of ZnCl 2 , CdCl 2 , or corticosterone into the same region, which was performed 24 h before the Aβ 1-42 injection (Fig. 2a-c) , consistent with blocking the increase in intracellular Zn 2+ in the dentate granule cell layer by preinjection of ZnCl 2 (Fig. 2d) . Even in the case of ZnCl 2 preinjection into young rats, it is estimated that induced MTs bind Zn 2+ released from Zn-Aβ 1-42 in dentate granule cells.
Dexamethasone-Induced MTs Rescue Aβ 1-42 -Induced Cognitive Decline
Intraperitoneal (i.p.) injection of dexamethasone increases MT-I messenger RNA (mRNA) in the brain, but not MT-III mRNA [6] . On the basis of the data that MT proteins were maximally increased in the hippocampus 24 h after i.p. injection of dexamethasone into young rats (Fig. 3a) , the effect of the increase was examined in ZnCl 2 -induced and Aβ 1-42 -induced attenuation of LTP. Both attenuations were rescued by the preinjection of dexamethasone prior to injection of ZnCl 2 or Aβ 1 -42 (Fig. 4a, b) . The preinjection of dexamethasone blocked Aβ 1-42 -induced increase in intracellular Zn 2+ in the dentate granule cell layer (Fig. 3c) . On the other hand, the preinjection did not modify Aβ 1-42 stain in the dentate granule cell layer (Fig.  3d) . Simultaneously, Aβ 1-42 -induced object recognition memory deficit was rescued in young rats, which were subjected to preinjection of dexamethasone in the same manner (Fig. 4d) . The preinjection of dexamethasone had no effect on object recognition memory.
To assess the effect of induced MTs on Zn 2+ -buffering, high K + -induced increase in intracellular Zn 2+ was compared between brain slices from the control and dexamethasonepretreated rats. The increase in intracellular Zn 2+ was suppressed in the dentate granule cell layer by the preinjection of dexamethasone (Fig. 3e) On the basis of the rapid uptakes of Aβ and Zn 2+ into young dentate granule cells [21] , it is possible that both uptakes are modified in aged dentate granule cells, consistent with age-related increase in extracellular zinc in the hippocampus [18] . To test age-related Aβ 1-42 retention in vivo, Aβ immunostaining was performed in the dentate gyrus captured 5 min after local injection of Aβ into the dentate granule cell layer of young and aged rats. Aβ 1-42 staining was more increased in the aged dentate granule cell layer, although it was not significant increase (Fig. 5a, b) . On the other hand, Aβ 1-42 -induced increase in intracellular Zn 2+ , which was measured with intracellular ZnAF-2, was significantly more in the aged dentate granule cell layer (Fig. 5c, d ). Both Aβ 1-42 staining and Aβ 1-42 -induced increase in intracellular Zn 2+ were blocked in both the young and aged dentate granule cell layers by coinjection of CaEDTA, an extracellular Zn 2+ chelator, suggesting that Aβ 1-42 uptake and Aβ 1-42 -induced increase in intracellular Zn 2+ require extracellular Zn 2+ even in aged rats.
The rapid Zn 2+ influx via Aβ 1-42 in aged rats implies agerelated vulnerability to Aβ 1-42 -induced synapse dysfunction. Aβ 1-42 injection (25 pmol) into the dentate granule cell layer, which rapidly increases intracellular Zn 2+ in the dentate granule cell layer [20] , attenuated LTP in young rats. However, the half dose of Aβ 1-42 (12.5 pmol) did not attenuate LTP (Fig. 6a) and did not increase intracellular Zn 2+ in the dentate Fig. 3 MT induction modifies intracellular Zn 2+ levels, but not intracellular Aβ levels. a Saline and dexamethasone sodium phosphate (DEX, 10 mg/kg) in saline were i.p. injected into young rats once a day for 2 days. Hippocampal MT proteins were determined 6 h (saline, n = 6; DEX, n = 4), 12 h (DEX, n = 4), 24 h (saline, n = 10; DEX, n = 9), 48 h (DEX, n = 5), and 72 h (saline, n = 4; DEX, n = 6) after the last injection of DEX. b Hippocampal MT proteins 24 h after DEX (10 mg/kg × 2) injection into young (saline, n = 17; DEX, n = 16) and aged (saline, n = 8; DEX, n = 10) rats. ***p < 0.001 vs. saline, # p < 0.05 vs. young saline. c Saline and DEX (10 mg/kg × 2) in saline were injected into young rats in the same manner as Fig. 3a . Twenty-four hours later, saline and 25 μM Aβ 1-42 in saline containing 100 μM ZnAF-2DA (2 μl) were bilaterally injected into the dentate granule cell layer. Five minutes later, intracellular ZnAF-2 fluorescence were captured in the same manner as Fig. 2d (left) . Intracellular Zn 2+ levels in the GCL (right). Saline/saline, n = 10; saline/ Aβ, n = 7; DEX/Aβ, n = 7. ***p < 0.001 vs. saline (control), ### p < 0.001 vs. saline/Aβ (Tukey's test). d Aβ 1-42 immunostaining was performed 5 min after bilateral injection of saline and 50 μM Aβ 1-42 in saline (2 μl) into the dentate granule cell layer of young rats pretreated with DEX in the same manner as Fig. 3c . Saline/saline, n = 10; saline/Aβ, n = 8; DEX/ Aβ, n = 8. *p < 0.05, ***p < 0.001 vs. saline (control) (Tukey's test). Brain slices were prepared from young (e) and aged (f) rats 24 h after DEX (10 mg/kg × 2) injection in the same manner as Fig. 3a , loaded with 10 μM ZnAF-2DA in ACSF for 30 min, and rinsed in ACSF for 10 min. The brain slices were transferred to a recording chamber filled with ACSF containing 10 nM ZnCl 2 and stimulated with high K + (final concentration of KCl, 50 mM) to measure the changes in intracellular Zn
2+
. Intracellular ZnAF-2 images before stimulation (0 s) and 300 s after stimulation (left). Changes in intracellular ZnAF-2 fluorescence in the GCL after stimulation (middle) and 300 s after stimulation (right). Young saline, n = 13; young DEX, n = 18; aged saline, n = 13; aged DEX, n = 9. *p < 0.05 vs. saline (t test) granule cell layer (Fig. 6c) . In contrast, LTP was attenuated 1 h after Aβ 1-42 injection (12.5 pmol) into the aged dentate granule cell layer (Fig. 6b) , which rapidly increased intracellular Zn 2+ in the aged dentate granule cell layer (Fig. 6d) . In aged rats, Aβ 1-42 -induced attenuation of LTP was rescued by coinjection of CaEDTA (Fig. 6b) . The basal level of MT proteins in the hippocampus, which was higher in aged rats than young rats, was also in saline (25 μM) (1 μl) were injected into DEX-pretreated young rats in the same manner as Fig. 4a (arrow) (left) . Saline/saline, n = 8; saline/Aβ, n = 8; DEX/Aβ, n = 5; DEX/saline, n = 5. ***p < 0.001 vs. saline, ### p < 0.001 vs. saline/Aβ (Tukey's test). c Saline and Aβ in saline (25 μM) (1 μl) were injected into DEX-pretreated aged rats in the same manner as Fig. 4a (arrow) (left) . Saline/saline, n = 15; saline/Aβ, n = 8; DEX/Aβ, n = 4; DEX/saline, n = 4. *p < 0.05 vs. saline, # p < 0.05 vs. saline/Aβ (Tukey's test). d One hour after pretreatment with DEX in the same manner as Fig. 3a , young rats were allowed to explore an open field for 10 min. Twenty-three hours later, saline or 25 μM Aβ 1-42 in saline (1 μl) were bilaterally injected into the dentate granule cell layer of the unanesthetized young rats. One hour after injection, the rats were trained and tested in a novel object recognition task. Saline/saline, n = 11; saline/Aβ, n = 11; DEX/Aβ, n = 9; DEX/saline, n = 8. **p < 0.01 vs. saline, # p < 0.05 vs. saline/Aβ 1-42 (Tukey's test). Note that recognition indices in the test were significantly (p < 0.01, t test) elevated in the saline, DEX/Aβ , and DEX/saline groups increased 24 h after i.p. injection of dexamethasone into aged rats (Fig. 3b) . High K + -induced increase in intracellular Zn 2+ was suppressed in the aged dentate granule cell layer, as well as the young dentate granule cell layer (Fig. 3e) , by the preinjection of dexamethasone (Fig. 3f) , suggesting that dexamethasone-induced MTs can buffer Zn 2+ released from Aβ in dentate granule cells of aged rats and rescue Aβ 1-42 -induced cognitive decline. Actually, Aβ 1-42 -induced attenuation of LTP was rescued in aged rats, as well as young rats (Fig.  4b) , by the preinjection of dexamethasone prior to Aβ 1-42 injection (Fig. 4c) . In vivo Aβ uptake and Aβ-mediated Zn 2+ uptake that require extracellular Zn 2+ are enhanced in aged dentate granule cells. a Fifty micromolar Aβ in ACSF (young, n = 13; aged, n = 11) and 50 μM Aβ 1-42 + 500 μM CaEDTA in ACSF (young, n = 11; aged, n = 12) were bilaterally injected into the dentate granule cell layer of anesthetized young and aged rats. Aβ immunostaining in the dentate gyrus were captured 5 min after injection. b Aβ 1-42 uptake in the GCL determined with Alexa 633 fluorescence, which is represented by the ratio to the young control without Aβ in ACSF expressed as 100%. **p < 0.01, ***p < 0.001 vs. control (young, n = 15; aged, n = 14), ## p < 0.01, ### p < 0.001 vs. Aβ (Tukey's test). c Fifty micromolar Aβ in ACSF (young, n = 8; aged, n = 7) and 50 μM Aβ 1-42 + 500 μM CaEDTA in ACSF (young, n = 6; aged, n = 4) containing ZnAF-2DA (100 μM) were bilaterally injected in the same manner as Fig. 5a . Intracellular Zn 2+ fluorescence was captured 5 min after injection as described in Fig. 2d. d Intracellular Zn 2+ level in the GCL determined with intracellular ZnAF-2 fluorescence, which is represented by the ratio to the young control without Aβ in ACSF expressed as 100%. *p < 0.05, ***p < 0.001 vs. control (young, n = 6; aged, n = 6), The lack of intracellular Zn 2+ in dentate granule cells induced by perfusion with ZnAF-2DA attenuates LTP [25] . We tested whether the lack of transient changes in intracellular Zn 2+ concentration, which is required for LTP, could be rescued by MT induction. LTP was attenuated 1 h after local injection of ZnAF-2DA into the dentate granule cell layer. ZnAF-2DA-induced attenuation of LTP was rescued by the preinjection of ZnCl 2 or CdCl 2 into the same region, which was performed 24 h before the ZnAF-2DA injection (Fig. 7a, b) . ZnAF-2DA- (Fig.  7c) . On the other hand, the preinjection of dexamethasone had no effect on LTP induction (Fig. 7c) , suggesting that dexamethasone-induced MTs do not affect LTP, as well as the cases of MT induction with ZnCl 2 , CdCl 2 , and corticosterone ( Figs. 1 and 2 ).
Discussion
MT-I and MT-II expressions are regulated by a wide variety of metals, hormones, and xenobiotics, while MT-III expression hardly responds to these stimuli [6, 26] . MT-III is upregulated by brain ischemia and plays an important role in protecting neurons from ischemic insult by decreasing neurotoxic Zn 2+ [27] . In contrast, MT-I and MT-II protect neuroglial cells from oxidative damage [28] . The evidence indicates that MT-III is hardly induced by increase in intracellular Zn 2+ in hippocampal neurons, while MT-I and MT-II expressions are responsive to it [29] . The basal concentration of intracellular (cytosolic) Zn 2+ is estimated to be less than 1 nM (~0.1 nM) [30, 31] . The rapid increase in free Zn 2+ in the intracellular compartment is a cause of age-related and Aβ 1-42 -induced cognitive decline in addition to neuronal death [18, 32] . Intracellular MTs can buffer free Zn 2+ based on its varying affinities for Zn 2+ [33, 34] , which physiologically overlap with cellular transient changes in Zn 2+ concentration, i.e., intracellular Zn 2+ signaling. However, it estimated that the binding capacity is saturated by the rapid increase in intracellular Zn 2+ , which is induced by glutamatergic synapse excitation with high K + [18, 19] and extracellular Aβ [20] . If intracellular Zn 2+ concentration reaches 10 nM, which is the estimated concentration of extracellular Zn 2+ [35] , MTs bind up to 7 equivalents of Zn 2+ and become the holo-MTs, Zn 7 MTs [36] , resulting in loss of the Zn 2+ -buffering ability. Therefore, it is thought that an increase in intracellular MTs is effective for buffering the rapid excess increase in intracellular Zn 2+ associated with cognitive decline, while an increase in extracellular MTs might not be effective for blocking extracellular Zn 2+ -dependent Zn-Aβ 1-42 uptake [21] .
To examine our idea, the rescuing effect of MT induction on excess Zn 2+ -induced attenuation of LTP was examined in young rats 24 h after local injection of three MT inducers. Excess Zn
2+
-induced attenuation of LTP, which was induced by Aβ injection into dentate granule cell layer, was rescued by the preinjection of ZnCl 2 , CdCl 2 , or corticosterone into the same region, consistent with blocking the rapid excess increase in intracellular Zn 2+ in dentate granule cells by preinjection of ZnCl 2 , suggesting that induced MT-I and MT-II proteins rescue Aβ 1-42 -induced attenuation of LTP.
MT proteins in the hippocampus were maximally increased 24 h after i.p. injection of dexamethasone. This increase subsequently rescued Aβ [36] . Although the mechanism of cellular Zn-Aβ 1-42 uptake is unknown, it is estimated that induced MTs do not affect extracellular Zn 2+ -dependent Zn-Aβ 1-42 uptake into dentate granule cells. Even if induced MTs are secreted from the cells [38, 39] , extracellular MTs readily become hono-MTs, Zn 7 MTs by binding to extracellular Zn 2+ under the condition of extracellular Zn 2+ concentration (10 nM) [36] , resulting in no effect on Zn-Aβ 1-42 uptake into dentate granule cells.
Judging from estimated increase in extracellular Zn 2+ and weakened intracellular Zn 2+ buffering in the process of aging [18, 40] , it is possible that extracellular Zn 2+ more frequently . Saline and Aβ in saline (1 μl) were injected in the dentate granule cell layer (arrow) of young (a) and aged (b) rats under anesthetized condition and HFS was delivered 1 h after injection (left). Saline, n = 7; 12.5 μM Aβ 1-42 , n = 4; 25 μM Aβ 1-42 , n = 4. *p < 0.05 vs. saline (Tukey's test) (a, middle). Saline, n = 15; 10 μM Aβ 1-42 , n = 4; 12.5 μM Aβ , n = 9; 12.5 μM Aβ 1-42 /500 μM CaEDTA, n = 9. *p < 0.05 vs. saline, # p < 0.05 vs. 12.5 μM Aβ 1-42 (Tukey's test) (b, middle). Representative fEPSP recordings at the time − 70 min (black line), − 20 min (gray line), and 50 min (red line) are shown (right). Scale bar, vertical axis (5 mV), cross axis (5 ms). Saline and 12.5 μM Aβ 1-42 in saline containing ZnAF-2DA (100 μM) (1 μl) were bilaterally injected into the dentate granule cell layer of anesthetized young (c) and aged (d) rats. Intracellular Zn 2+ fluorescence was captured 5 min after injection as described in Fig. 2d (left) . Intracellular Zn 2+ level in the GCL determined in the same manner as Fig. 2d (right) . Young saline, n = 14; young Aβ, n = 16; aged saline, n = 13; aged Aβ, n = 10. *p < 0.05 vs. saline (t test)
captures Aβ and that Zn-Aβ 1-42 formed is rapidly taken up into aged dentate granule cells, resulting in enhanced vulnerability of aged dentate granule cells to Zn 2+ released from Aβ . This process leads the elderly to an increased risk of Zn-Aβ 1-42 -induced cognitive decline. Both uptakes of Aβ and Zn 2+ into dentate granule cells were enhanced in aged rats, supporting age-related increase in the risk. Furthermore, LTP induction was more vulnerable to Aβ in aged dentate gyrus, consistent with enhanced Aβ 1-42 -mediated Zn 2+ uptake into aged dentate granule cells. Hippocampal MTs induced with dexamethasone also rescued the vulnerability of aged dentate granule cells to Aβ 1-42 -induced attenuation of LTP. Therefore, once ferried by Aβ 1-42 into dentate granule cells, the Zn 2+ cargo is released in dentate granule cells. This encounter may be facilitated in the normal aging process. Synaptic activity increases both extracellular Aβ [41, 42] and extracellular Zn 2+ at zincergic synapses [4] . So, we hypothesize that a decrease in clearance mechanisms in aging process may lead to the inappropriate combination of Zn . a Saline and ZnCl 2 in saline (100 μM) (1 μl) were injected into the dentate granule cell layer, and then, saline and ZnAF-2DA in saline (100 μM) (1 μl) were injected 23 h after the injection as shown by the arrow in the same manner as Fig. 1 (left) . Saline/saline, n = 17; saline/ ZnAF-2DA, n = 10; ZnCl 2 /ZnAF-2DA, n = 7; ZnCl 2 /saline, n = 4. *p < 0.05 vs. saline, # p < 0.05, ### p < 0.001 vs. saline/ZnAF-2DA (Tukey's test) (middle). Representative fEPSP recordings at the time − 24 h (black line), − 20 min (gray line), and 50 min (red line) are shown (right). Scale bar, vertical axis (6 mV), cross axis (5 ms). b Saline and CdCl 2 in saline (100 μM) (1 μl) were injected and treated in the same manner as a (left). Saline/saline, n = 17; saline/ZnAF-2DA, n = 10; CdCl 2 / ZnAF-2DA, n = 8; CdCl 2 /saline, n = 5. *p < 0.05 vs. saline, # p < 0.05 vs. saline/ZnAF-2DA (Tukey's test) (middle). c Saline and ZnAF-2DA in saline (100 μM) (1 μl) were injected into DEXpretreated young rats in the same manner as Fig. 4a (arrow) and HFS was delivered 1 h after injection (left). Saline/saline, n = 8; saline/ZnAF-2DA, n = 7; DEX/ZnAF-2DA, n = 7; DEX/saline, n = 5. ***p < 0.001 vs. saline, for metal chelation-based drug therapy has been reported for AD. Clioquinol, a copper/zinc ionophore, reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in the brain of the AβPP/PS1 transgenic mouse [44] . It also promotes the degradation of metal-dependent Aβ oligomers to restore endocytosis and ameliorates Aβ toxicity [45] . PBT2, a secondgeneration 8-hydroxyquinoline analog, significantly lowers Aβ levels in the cerebrospinal fluid and improves cognitive performance over baseline in several key executive function tests [46, 47] . In contrast, MTs are non-toxic and functional as endogenous metal chelators. MT induction is an attractive strategy for defending Aβ 1-42 -induced cognitive decline, and this novel defense strategy may lead to preventing and/or delaying AD pathogenesis. It needs to clarify an effective procedure to induce hippocampal MTs that continuously defend Aβ 1-42 -induced cognitive decline via free Zn 2+ . Finally, we tested whether MTs could deliver Zn 2+ in LTP induction. The lack of intracellular Zn 2+ , which was induced by injection of ZnAF-2DA into the dentate granule cell layer, attenuated LTP, and the attenuation was rescued by preinjection of Zn 2+ and Cd 2+ into the same region. It is possible that ZnAF-2DA captures extracellular Zn 2+ and Zn-bound ZnAF-2DA is taken up into neurons. In the case of injection of 100 μM ZnAF-2DA into the extracellular compartment (extracellular Zn
:ZnAF-2DA = 1:10,000), however, it is likely that a major portion of ZnAF-2DA taken up into neurons is the form without Zn levels, and its occupying rate is lowered under the lack of intracellular Zn 2+ [36] . Nonetheless, the present data first indicate that induced MTs deliver Zn 2+ to Zn 2+ -required proteins, which are required for LTP and plastic changes in synapse structure, under the acute lack of intracellular Zn 2+ . Induced apo-MTs increase the influx of extracellular Zn 2+ for binding Zn 2+ , while they do not modify the basal level of intracellular Zn 2+ required for synapse function such as LTP. Thus, MTs may serve as a member for functional Zn 2+ buffering in cognitive activity. However, the Zn 2+ -buffering system may be weakened in the aged dentate gyrus, probably due to characteristics (easiness) of extracellular Zn 2+ influx [18, 40] . The characteristics might be associated with the high basal level of MT proteins in the aged hippocampus, perhaps a compensative mechanism. However, intracellular Zn 2+ regulation via MTs remains unclear.
In summary, hippocampal MT induction may rescue cognitive decline under lack of cellular transient changes in functional Zn 2+ concentration, while its induction is an attractive defense strategy against Aβ 1-42 -induced cognitive decline, which is due to excess increase in intracellular Zn 2+ .
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